530 related articles for article (PubMed ID: 24607436)
21. Unusual early bile excretion from the liver in patients with fulminant hepatic failure as detected by Tc-99m-PMT hepatobiliary scintigraphy; comparison with Tc-99m-GSA scintigraphy.
Matsuoka S; Uchiyama K; Kuniyasu Y; Niio Y; Hasebe S; Shima H; Oishi S; Nojiri Y; Ogata H
Ann Nucl Med; 2001 Feb; 15(1):57-60. PubMed ID: 11355784
[TBL] [Abstract][Full Text] [Related]
22. Imaging of hepatic drug transporters with [
Kobayashi M; Nishi K; Mizutani A; Hokama T; Matsue M; Tsujikawa T; Nakanishi T; Nishii R; Tamai I; Kawai K
Sci Rep; 2019 Sep; 9(1):13413. PubMed ID: 31527775
[TBL] [Abstract][Full Text] [Related]
23. Different Efflux Transporter Affinity and Metabolism of
Kobayashi M; Tsujiuchi T; Okui Y; Mizutani A; Nishi K; Nakanishi T; Nishii R; Fukuchi K; Tamai I; Kawai K
Pharm Res; 2018 Nov; 36(1):18. PubMed ID: 30498970
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
Lepist EI; Gillies H; Smith W; Hao J; Hubert C; St Claire RL; Brouwer KR; Ray AS
PLoS One; 2014; 9(1):e87548. PubMed ID: 24498134
[TBL] [Abstract][Full Text] [Related]
25. Identification of the transporters involved in the hepatobiliary transport and intestinal efflux of methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) glucuronide, a pharmacologically active metabolite of S-8921.
Sakamoto S; Kusuhara H; Horie K; Takahashi K; Baba T; Ishizaki J; Sugiyama Y
Drug Metab Dispos; 2008 Aug; 36(8):1553-61. PubMed ID: 18474677
[TBL] [Abstract][Full Text] [Related]
26. Lack of Contribution of Multidrug Resistance-associated Protein and Organic Anion-transporting Polypeptide to Pharmacokinetics of Regorafenib, a Novel Multi-Kinase Inhibitor, in Rats.
Hotta K; Ueyama J; Tatsumi Y; Tsukiyama I; Sugiura Y; Saito H; Matsuura K; Hasegawa T
Anticancer Res; 2015 Sep; 35(9):4681-9. PubMed ID: 26254357
[TBL] [Abstract][Full Text] [Related]
27. Tc-99m PMT scintigraphy in the diagnosis of pediatric biliary atresia.
Tsuda N; Shiraishi S; Sakamoto F; Ogasawara K; Tomiguchi S; Yamashita Y
Jpn J Radiol; 2019 Dec; 37(12):841-849. PubMed ID: 31571132
[TBL] [Abstract][Full Text] [Related]
28. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
Kunze A; Huwyler J; Camenisch G; Poller B
Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
[TBL] [Abstract][Full Text] [Related]
29. Hepatic uptake and excretion of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel if channel inhibitor, in rats and humans.
Umehara K; Iwai M; Adachi Y; Iwatsubo T; Usui T; Kamimura H
Drug Metab Dispos; 2008 Jun; 36(6):1030-8. PubMed ID: 18332079
[TBL] [Abstract][Full Text] [Related]
30. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
Kindla J; Müller F; Mieth M; Fromm MF; König J
Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
[TBL] [Abstract][Full Text] [Related]
31. [The utility of quantitative 99mTc-GSA liver scintigraphy in the evaluation of hepatic functional reserve: comparison with 99mTc-PMT and 99mTc-Sn colloid].
Shuke N; Aburano T; Nakajima K; Yokoyama K; Sun BF; Matsuda H; Muramori A; Michigishi T; Tonami N; Hisada K
Kaku Igaku; 1992 May; 29(5):573-84. PubMed ID: 1434071
[TBL] [Abstract][Full Text] [Related]
32. Identification of Transporters Involved in Beraprost Sodium Transport In Vitro.
Oshida K; Shimamura M; Seya K; Ando A; Miyamoto Y
Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):117-128. PubMed ID: 26961540
[TBL] [Abstract][Full Text] [Related]
33. Organic Anion-Transporting Polypeptide and Efflux Transporter-Mediated Hepatic Uptake and Biliary Excretion of Cilostazol and Its Metabolites in Rats and Humans.
Wang C; Huo X; Wang C; Meng Q; Liu Z; Sun P; Cang J; Sun H; Liu K
J Pharm Sci; 2017 Sep; 106(9):2515-2523. PubMed ID: 28535976
[TBL] [Abstract][Full Text] [Related]
34. Assessment of drug transporters involved in the urinary secretion of [
Kobayashi M; Mizutani A; Okamoto T; Muranaka Y; Nishi K; Nishii R; Shikano N; Nakanishi T; Tamai I; Kleinerman ES; Kawai K
Nucl Med Biol; 2021; 94-95():92-97. PubMed ID: 33609918
[TBL] [Abstract][Full Text] [Related]
35. Glycyrrhizin has a high likelihood to be a victim of drug-drug interactions mediated by hepatic organic anion-transporting polypeptide 1B1/1B3.
Dong J; Olaleye OE; Jiang R; Li J; Lu C; Du F; Xu F; Yang J; Wang F; Jia W; Li C
Br J Pharmacol; 2018 Sep; 175(17):3486-3503. PubMed ID: 29908072
[TBL] [Abstract][Full Text] [Related]
36. Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein.
Matsushima S; Maeda K; Kondo C; Hirano M; Sasaki M; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 2005 Sep; 314(3):1059-67. PubMed ID: 15901800
[TBL] [Abstract][Full Text] [Related]
37. Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans.
Shimizu M; Fuse K; Okudaira K; Nishigaki R; Maeda K; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2005 Oct; 33(10):1477-81. PubMed ID: 16014768
[TBL] [Abstract][Full Text] [Related]
38. [Clinical evaluation of kinetic model for the quantification of liver function with Tc-99m PMT and dynamic scintigraphy].
Tsuda T
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Sep; 54(10):1030-40. PubMed ID: 7971181
[TBL] [Abstract][Full Text] [Related]
39. [Hepatobiliary functions in primary biliary cirrhosis--assessment with 99mTc-PMT hepatobiliary scintigraphy].
Imai Y
Kaku Igaku; 1994 Mar; 31(3):249-56. PubMed ID: 8176863
[TBL] [Abstract][Full Text] [Related]
40. Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein.
de Waart DR; Häusler S; Vlaming ML; Kunne C; Hänggi E; Gruss HJ; Oude Elferink RP; Stieger B
J Pharmacol Exp Ther; 2010 Jul; 334(1):78-86. PubMed ID: 20388726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
